Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PDT for Seborrheic Dermatitis
NCT03114111Phase 1Completed
- Sponsor
- University of California, Davis
- Start
- Jan 2017
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of aminolevulinic acid in seborrheic dermatitis (SD), sponsored by University of California, Davis. Primary endpoint: Seborrhea Area and Severity Index Face at 3 months. Started Jan 2017; status: completed.
02
Drugs
aminolevulinic acid
03
Conditions
seborrheic dermatitis (SD)
Beyond the preview
Go deeper on NCT03114111.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03114111.